Skip to main content
. 2020 Jan 20;20:31. doi: 10.1186/s12883-020-1603-0

Table 3.

Analysis of factors regarding favorable outcome (mRS < 3) using univariable regression or Fisher’s exact test; n = 150

favorable outcome (n = 17) median or n (p25; p75 or %) unfavorable outcome (n = 133) median or n (p25; p75 or %) OR (95% CI) p
Baseline characteristics
 Age (median, y) 58 (50; 63) 57 (50; 64) 1.00 (0.96–1.05) 0.884
 Female sex (n) 13 (76%) 94 (71%) 1.35 (0.41–4.39) 0.620
 First degree relatives with SAH (n) 0 5 (4%) 1.000±
 mRS before admission (median) 0 (0; 0) 0 (0; 0) 1.08 (0.40–2.87) 0.883
 Addiction to alcohol (n) 3 (18%) 9 (7%) 2.95 (0.71–12.20) 0.135
 Arterial hypertension (n) 10 (59%) 77 (58%) 1.04 (0.37–2.90) 0.942
 Aspirin (n) 1 (6%) 15 (11%) 0.49 (0.06–4.00) 0.506
 Oral anticoagulation (n) 0 6 (5%) 1.000±
 Aneurysm size (median, mm) 5 (4; 7) 6 (4; 9) 0.87 (0.73–1.04) 0.132
 Hunt-Hess score on admission (median) 3 (2; 3) 4 (3; 5) 0.60 (0.40–0.88) 0.010*
Aneurysm location
  Anterior communicating artery 7 (41%) 43 (32%) 2.60 (0.30–22.87) 0.388
  Middle cerebral artery 2 (12%) 27 (20%) 1.19 (0.10–14.14) 0.893
  Posterior communicating artery 3 (18%) 15 (11%) 3.20 (0.30–34.24) 0.336
  Basilar artery 1 (6%) 16 (%) base
  Posterior inferior cerebellar artery 0 10 (8%)
  Internal carotid artery 1 (6%) 9 (7%) 1.78 (0.10–31.98) 0.696
  Anterior cerebral artery 0 6 (5%)
  Vertebral artery 1 (6%) 3 (2%) 5.33 (0.26–110.80) 0.279
  Posterior cerebral artery 0 3 (2%)
  Superior cerebellar artery 1 (6%) 1 (1%) 16.00 (0.52–494.00) 0.113
  Anterior inferior cerebellar artery 1 (6%) 0
Treatment modality
 Coiling 12 (71%) 71 (53%) 1.55 (0.51–4.71) 0.435
 Clipping 5 (29%) 46 (35%) base
 Coiling and clipping 0 4 (3%)
 Flow diverter 0 1 (1%)
 No intervention 0 11 (8%)
Complications
 Hydrocephalus (n) 14 (82%) 108 (81%) 1.08 (0.29–4.05) 0.909
 Pneumonia (n) 6 (35%) 82 (62%) 0.34 (0.12–0.97) 0.044*
 Fever (h, median) 15 (3; 25) 8 (1; 45) 1.00 (0.99–1.01) 0.506
 Vasospasm (n) 11 (65%) 82 (62%) 1.14 (0.40–3.27) 0.807
 Rebleeding (n) 1 (6%) 35 (26%) 0.18 (0.02–1.37) 0.097
 Seizure (n) 2 (12%) 41 (31%) 0.30 (0.07–1.37) 0.120
 Delayed cerebral ischemia (n) 4 (24%) 70 (53%) 0.28 (0.09–0.89) 0.032*
 Intraparenchymal hemorrhage (n) 2 (12%) 47 (35%) 0.24 (0.05–1.11) 0.068
 Need for ventricular/lumbar drainage (n) 15 (88%) 126 (95%) 0.42 (0.08–2.19) 0.301
 Length of stay (d, median) 21 (16; 30) 19 (11; 25) 1.01 (0.99–1.04) 0.285
ventilation parameters
 Horowitz index (PaO2/FiO2, median) 360 (297; 395) 277 (225; 329) 1.01 (1.00–1.02) 0.005*
 Proportion of values of PaCO2 > 40 mmHg 0.21 (0.13; 0.5) 0.4 (0.29; 0.59) 0.04 (0.00–0.55) 0.017*
 Driving pressure (mbar, median) 13 (12; 14) 13 (12; 15) 0.90 (0.73–1.12) 0.347
 Tidal volume (ml, median) 550 (499; 592) 520 (473; 579) 1.00 (1.00–1.01) 0.357
 pH (median) 7.42 (7.39; 7.44) 7.43 (7.40; 7.45) 0.223
 Ventilation time (h, median) 42 (21; 84) 346 (171; 538) 0.99 (0.99–1.00) 0.001*
 FiO2 (median) 0.30 (0.30–0.35) 0.35 (0.30–0.40) 0.90 (0.82–0.99) 0.034*
 Intracranial pressure (mm Hg, median) 5 (3; 7) 8 (5; 11) 0.84 (0.73–0.96) 0.013*

OR odds ratio and 95% CI; all p-values derived from logistic regression except ±Fisher’s exact test; *significant; ASA Acetylsalicylic acid, Mann-Whitney-U test; univariable logistic regression did not converge